SYH-2083 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,822 results for “SYH-2083”

Trials

View all 761 →

A Study to Evaluate the Efficacy and Safety of AD-208

139 participants · First posted Apr 1, 2021

Tinnitus rTMS 2013

80 participants · First posted Aug 28, 2013

Rehabilitation of Patients After Subarachnoid Hemorrhage

171 participants · First posted Aug 2, 2012

Drugs

View all 940 →

SYH-2053

SYH-2043

SYH-2038

Organizations

BIRENDRA KUMAR SAH

India

BILECIK SEYH EDEBALI UNIVERSITESI

Turkey

SCH CORE ETF UNITS

News

View all 115 →

China NMPA Clears CSPC's SYH-2083 for Clinical Trials in Dry Eye Disease

CSPC Pharma Advances Pipeline with Clinical Trial Approval for Leuprolide Acetate Sustained-Release Injection

Repare Therapeutics' Gynecological Cancer Trial Shows Mixed Results, Beigene Inks $1.5B Deal for MAT2A Inhibitor

Page 1 of 183